PRAB yields 7.98% · JNJ yields 2.14%● Live data
📍 PRAB pulled ahead of the other in Year 1
Combined, PRAB + JNJ cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of PRAB + JNJ for your $10,000?
The State Street IG Public & Private ABS ETF (PRAB) is an actively-managed fund primarily allocating to investment grade asset-backed securities (“ABS”), including both public and private ABSPRAB, through active security selection, may invest in a wide range of investment-grade ABS, including collateralized loan obligations and residential and commercial mortgage-backed securities. PRAB seeks to maximize risk-adjusted returns alongside current incomePRAB is managed by State Street Investment Management’s Active Fixed Income Team, and the portfolio managers use a risk-aware, top-down approach combined with bottom-up security selection to construct a portfolio that seeks to overweight the most attractive sectors and issuersPRAB may invest in private ABS, including those sourced by Apollo Global Securities, LLC (“AOS Investments”) and those allocation percentages may vary
Full PRAB Calculator →Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide, but strategically separated its Consumer Health business into Kenvue Inc. in 2023 to focus on its higher-growth, innovation-driven segments; the former Consumer Health brands (including TYLENOL, LISTERINE, and BAND-AID) are now owned by Kenvue. The company's core focus is now split between its Innovative Medicine (formerly Pharmaceutical) segment, which offers prescription products for complex diseases such as rheumatoid arthritis, various cancers, HIV/AIDS, and neurodegenerative disorders; and its MedTech (Medical Devices) segment, which provides advanced technology solutions including electrophysiology products, neurovascular care products, orthopaedics (hips, knees, spine), advanced surgery solutions, and disposable contact lenses under the ACUVUE brand. Company's two remaining segments primarily serve hospitals, healthcare professionals, wholesalers, and retailers, continuing its mission of advancing human health since its founding in 1886 and its current basing in New Brunswick, New Jersey.
Full JNJ Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.